Tempus is a Chicago-based company that was founded in 2012. It helps physicians in making more informed, educated, personalized, and optimized cancer therapy decisions. The company has already earned a place among the top ten health techs in the city. Recently, Eric Lefkofsky, the co-founder of Tempus, announced that it raised another 110 million dollars from existing and new investors. The company also raised 80 million in March this year. Tempus collects and analyzes data for physicians to use in the treatment of cancer. The company built a platform for collecting, structuring, and analyzing clinical data, like information from charts that’s usually not organized in electronic medical record systems.
The company is also generating genomic data by sequencing the DNA of patients plus other information in its laboratory. According to the company, physicians using Tempus’ technology will gain insights into how they can better treat their cancer patients. Tempus is typically using clinical data to discover trends in cancer treatment overall as well as collect molecular data from those undergoing treatment. Lefkofsky said that in some cases, the data collection process can be just digitizing the handwritten patient notes from the doctor so that they’re searchable, and they can be stored for the purpose of expanding on treatment options.
This rift between the patient data that’s collected and the use of the information on creating effective treatment is due to the fact that not all data of patients are accessible. Tempus partners with over 50 National Cancer Institute (NCI)-designated cancer centers. Eric Lefkofsky stated that Tempus’ technology is being used by physicians in the treatment of one in four cancer patients in the United States. Investors in this latest round include Baillie Gifford, an investment management firm based in the united kingdom and Revolution Growth, a venture capital firm based in Washington, D.C.
Blood in urine without painful urination may be a first symptom of bladder cancer says expert urologist, Dr. David Samadi. Men are about three times more likely to be affected by this cancer, and it is usually discovered between the ages of 65 and 70 years. Dr. Samadi says becoming aware of the risk factors can help change bad habits and diminish the risk of getting the disease.
Risk factors include tobacco smoking, exposure to certain chemicals and chronic cystitis . Dr. David Samadi explains how bladder cancer develops, and how to reduce risk factors.
— Dr. David Samadi (@drdavidsamadi) April 8, 2018
What is Bladder Cancer?
The term bladder cancer refers to all malignant growths that originate in the urinary bladder. Normally the growth of human cells is strongly regulated by the body. If these regulatory mechanisms fail, the cells can divide and multiply more quickly and uncontrollably. These cell changes are the basis for any malignant tumor.
In most cases, tumors arise from the surface tissue of the bladder , called urothelium, which is why bladder cancer is also called urothelial carcinoma, says Dr. Samadi. Urothelial carcinomas can also occur in the renal pelvis, in the ureter and in the urethra. Rarely, bladder cancer can also emanate from the muscles of the bladder.
Before the cells of the urinary bladder wall change, they are usually made more sensitive to degeneration by certain stimuli . These risk factors increase the likelihood of developing bladder cancer. An important factor is, for example, tobacco smoking . Smokers are about four times more likely than non-smokers to contract bladder cancer.
Another cause of bladder cancer is because of carcinogenic influences of certain substances, and parasitic infections that increase cancer risk.
How Can You Protect Yourself From Bladder Cancer?
There is no sure protection against cancer. However, you can reduce the risk factors that are commonly associated with bladder cancer. There’s an increased risk of bladder cancer due to frequent use of cancer-causing substances, and the risk increases with certain jobs, like for firefighters, Industrial and construction workers, plant workers, and painters, just to name a few. For a favorable prognosis it is crucial that the bladder carcinoma is recognized in time. But early symptoms do not exist in this disease. The tumor can grow unnoticed for years, says Dr. Samadi. Individuals who work in these industries should consult a urologist more frequently.
Dr. David Samadi received his undergraduate and medical degree from Stony Brook University. After a Residency in Urology at Albert Einstein Medical Center, he completed a fellowship in Urologic Oncology at Memorial Sloan Kettering Cancer Center. Dr. Samadi previously served as Director of Urology at Columbia Presbyterian Hospital and currently serves as Chairman of Urology and Chief of Robotic Surgery at Lenox HIll Hospital.
Dr. Samadi’s primary focal point has been on urologic diseases for the last decade, and he has been the source of one of the most recent important developments in prostate cancer treatment. He developed the SMART surgical technique to remove prostate cancer, using robotic enhancements, with a 90 percent success rate, and faster recovery time for patients.
To know more click: here.
For Jason Hope, technology and business have formed part of his life and career. This is what has helped him tick in all aspects.
For him, he sees technology as a way of alleviating the various problems that bedevil the society at this point. He says that we are living in exciting times where different technological trends are emerging with each passing day.
The growing number of the Internet of Things (IoT) is what particularly excites him in this technological advancements era.
Born in the state of Arizona, Jason was privileged to get the best education. He went to the Arizona State University for his undergraduate finance degree and postgraduate MBA degree respectively.
Hope has different roles attached to him. He is an entrepreneur, philanthropist, futurist, and investor. Jason has an undying passion for technology and giving back to the community, and more information click here.
His love for technology has seen him nurture ideas of young entrepreneurs. Through his website, Jason can choose the exciting plans, and he helps the young entrepreneurs to grow them into meaningful businesses and investments.
For him it’s all about having the most straightforward design, communicating the ideas to relevant and close people, receiving feedback and working on building the concept up. This way of thinking is what he attributes to his success and something that aids him in bringing ideas to life.
Regarding business ideas, Jason tells the young entrepreneurs that areas such as Social media jobs and Internet Marketing offer the best opportunity for someone to kick-start his business.
He says with the right skills, and mentorship one can comfortably establish a stable and prosperous career.
As a businessman, Jason hope believes it’s good to manage one’s contacts and projects in a very orderly manner.
This is why he makes good use of ASANA a software application that allows him to manage his projects and tasks well enough. He says this app alongside proper networking and keeping close contact with referrals has worked for his good.
Besides his entrepreneurship, Jason is also passionate about medical technology and philanthropy. He has been able to donate part of his wealth to promoting research work about anti-aging prevention and cure research, and Jason Hope’s lacrosse camp.
Jason believes that through medical technology diseases such as Parkinson and other aging-related medical condition can be solved.
One such organization he has helped is SENS foundation that deals with medical research in aging medical conditions.
For him, it’s all about making a difference in the society in any way possible without fear or doubt.
Clay Siegall is one of the most influential names in the genetics industry. He strongly believes that genetics can help open doors for doctors around the world. He thinks that genetic therapy can cure cancer and several other diseases. Clay is extremely insightful and he is well-respected throughout the biotechnology field.
Siegall founded Seattle Genetics in the late nineties. When he started the company his goal was to develop antibody-based treatments. His leadership has allowed the company to develop several antibody-based therapies to meet the needs of cancer patients. These therapies have been extremely effective and have led to a greater quality of life for cancer patients everywhere. Seattle Genetics launched their first product, ADCETRIS, in 2011. The company now has a large pipeline of therapies set to come out in the coming years. Siegall believes that the company should work closely with other biotechnology companies to produce the best possible products. He wants to best serve patients around the world, and he knows that collaboration is the key to properly serving patients throughout the world.
Siegall loves working with other biotechnology companies. Recently, Siegall was appointed to the board of directors for Mirna Therapeutics. Mirna is a biotechnology company based in Austin. They primarily focus on developing microRNA therapies. Their therapies are extremely impactful, but they want as much insight as possible. Clay Siegall will bring years of medical experience to the company, and he hopes to lead them to new heights.
Clay also serves on the Ultragenyx board. Ultragenyx is an extremely powerful pharmaceutical company. They added Siegall to their board two year ago, and they are extremely happy to have his insight on their board. Clay has years of experience working with biotechnology, and he wants to help Ultragenyx develop new technologies that will help patients. His collaborative personality has been a major asset for the company.
Genetics can cure many different diseases, and Seattle Genetics intends to play a huge role in these cures. They have unveiled several successful products and they intend to keep revealing products for years to come. Clay Siegall is a brilliant leader and he will work with Seattle Genetics for years to come.